Taysha Gene Therapies (TSHA) Event June 21, 2022, 20:01 UTC 11 1 comments (99% Neutral) Taysha Gene Therapies, Inc. (TSHA) Files Form 8-K Comment Full text
Alector Inc (ALEC) Event June 21, 2022, 20:01 UTC 11 1 comments (99% Neutral) Alector, Inc. (ALEC) Announces Regulatory Update Comment Full text
Turning Point Therapeutics (the company was acquired by Bristol-Myers Squibb Company (NYSE : BMY)) (TPTX) Event June 21, 2022, 20:01 UTC 11 1 comments (99% Neutral) Turning Point Therapeutics, Inc. (TPTX) Announces Regulatory Update Comment Full text
Abcellera Biologics Inc (ABCL) Event June 21, 2022, 16:28 UTC 11 1 comments (50% Neutral) ABCELLERA BIOLOGICS INC. (ABCL) Announces Regulatory Update Comment Full text
Generation Bio (GBIO) Event June 21, 2022, 12:36 UTC 11 1 comments (99% Positive) Generation Bio Co. (GBIO) Announces Clinical Development Update Comment Full text
Genmab (GMAB) Event June 21, 2022, 12:33 UTC 10 1 comments (99% Neutral) Genmab (GMAB) Announces Clinical Development Update (Form 6-K) Comment Full text
Immunic Inc (IMUX) Event June 21, 2022, 12:31 UTC 11 1 comments (99% Neutral) IMMUNIC, INC. (IMUX) Files Form 8-K Comment Full text
PTC Therapeutics Inc (PTCT) Event June 21, 2022, 12:15 UTC 11 1 comments (19% Negative) PTC THERAPEUTICS, INC. (PTCT) Files Form 8-K Comment Full text
Recursion Pharmaceuticals Inc (RXRX) Event June 21, 2022, 12:04 UTC 11 1 comments (80% Positive) RECURSION PHARMACEUTICALS, INC. (RXRX) Announces Enrollment Update for designations Due to Pandemic-Related Challenges, Patient Enrollment Issues, Regulatory Process, Safety Review, Efficacy Assessment Comment Full text
Prelude Therapeutics (PRLD) Event June 21, 2022, 12:00 UTC 11 1 comments (99% Neutral) Prelude Therapeutics Inc (PRLD) Files Form 8-K Comment Full text